v3.25.4
Segment financial information - reported segments (Details)
$ in Millions
12 Months Ended
Dec. 31, 2025
USD ($)
segment
Dec. 31, 2024
USD ($)
segment
Dec. 31, 2023
USD ($)
Segment Reporting Information [Line Items]      
Number of reportable segments | segment 2 3  
Information by reportable segment      
Net sales $ 6,552.2 $ 6,783.6 $ 6,967.2
Adjusted Operating Income 957.8 1,089.8 1,211.8
Corporate      
Information by reportable segment      
Net sales 0.0 0.0 0.0
Adjusted Operating Income (70.4) (66.4) (58.4)
Laboratory Solutions | Operating Segments      
Information by reportable segment      
Net sales 4,399.7 4,610.1 4,738.3
Adjusted Operating Income 510.4 598.0 668.3
Bioscience Production | Operating Segments      
Information by reportable segment      
Net sales 2,152.5 2,173.5 2,228.9
Adjusted Operating Income $ 517.8 $ 558.2 $ 601.9